Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Liabilities (2016 - 2025)

Surgery Partners' Total Liabilities history spans 12 years, with the latest figure at $6.4 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 11548.73% year-over-year to $6.4 billion; the TTM value through Dec 2025 reached $6.4 billion, up 11548.73%, while the annual FY2025 figure was $6.4 billion, 11548.73% up from the prior year.
  • Total Liabilities for Q4 2025 was $6.4 billion at Surgery Partners, up from $41.5 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $6.4 billion in Q4 2025 and bottomed at $19.1 million in Q3 2021.
  • The 5-year median for Total Liabilities is $49.8 million (2023), against an average of $2.0 billion.
  • The largest annual shift saw Total Liabilities soared 19885.51% in 2022 before it tumbled 99.06% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $20.1 million in 2021, then surged by 103.48% to $40.9 million in 2022, then rose by 0.73% to $41.2 million in 2023, then skyrocketed by 33.5% to $55.0 million in 2024, then skyrocketed by 11548.73% to $6.4 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Total Liabilities are $6.4 billion (Q4 2025), $41.5 million (Q3 2025), and $4.8 billion (Q2 2025).